Metabolic profile of patients after heart transplantation

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F13%3A00069143" target="_blank" >RIV/00216224:14110/13:00069143 - isvavai.cz</a>
Alternative codes found
RIV/00159816:_____/13:00060610
Result on the web
<a href="http://dx.doi.org/10.1016/j.crvasa.2013.06.010" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2013.06.010</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.crvasa.2013.06.010" target="_blank" >10.1016/j.crvasa.2013.06.010</a>

Result language
angličtina
Original language name
Metabolic profile of patients after heart transplantation
Original language description
Orthotopic heart transplantation improves life expectancy and quality of life in patients with severe heart failure. After transplantation, metabolic complications are frequent. They are caused particularly by immunosuppressive therapy. In our cohort of315 patients, 52% of patients had diabetes mellitus together with hyperlipoproteinemia, 41% of patients had hyperlipoproteinemia without diabetes, 3% of patients had diabetes mellitus without hyperlipoproteinemia and only 4% of patients had none of thesedisorders. Therapeutic options with respect to interactions with immunosuppressive therapy are discussed in this article.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
<a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)